ND

Neeraj Deewan

Director Whole-Time Director DIN 01936889
DIN 01936889 First appointment Feb 1997 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 1997
Shareholding value β€’β€’β€’β€’ Premium profile

About Neeraj Deewan

Data last updated:

Neeraj Deewan was a Whole-Time Director at Medicross Pharma-Chem Limited (1997–2022) and Director at Medicross Medicaments Limited (from 2011). The companies operate in Healthcare.

DIN 01936889
Primary Designation Whole-Time Director
Industry Healthcare
First Appointment 28 Feb 1997
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicross Pharma-Chem Limited U24231DL1996PLC082346
Whole-Time Director28 Feb 19971996₹7.48 Cr (FY 2025)Active
Medicross Medicaments Limited U24232DL2011PLC213715
Director10 Feb 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medicross Medicaments Limited
Medicross Pharma-Chem Limited
Premium access

Shareholding and investment profile for Neeraj Deewan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Deewan

Neeraj Deewan was first appointed on 28 Feb 1997 as Whole-Time Director at Medicross Pharma-Chem Limited. The most recent appointment on record is 10 Feb 2011 at Medicross Medicaments Limited.

Neeraj Deewan held 2 earlier board appointments: Medicross Pharma-Chem Limited (Whole-Time Director, 28 Feb 1997 to 20 Nov 2022); Medicross Medicaments Limited (Director, from 10 Feb 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available